title: Performance-enhancing effects of non-selective endothelin receptor antagonist.
authors.affiliation: Center for Health, Exercise and Sport Sciences, Belgrade, Serbia; Faculty of Sport and Physical Education, University of Novi Sad, Novi Sad, Serbia. Electronic address: sergej.ostojic@chess.edu.rs.
authors.forename: Sergej M
authors.initials: SM
authors.lastname: Ostojic
authors.affiliation: Center for Health, Exercise and Sport Sciences, Belgrade, Serbia; Faculty of Sport and Physical Education, University of Novi Sad, Novi Sad, Serbia.
authors.forename: Marko
authors.initials: M
authors.lastname: Stojanovic
authors.affiliation: Center for Health, Exercise and Sport Sciences, Belgrade, Serbia; Faculty of Sport Sciences, University of the Basque Country, Vitoria-Gasteiz, Spain.
authors.forename: Julio
authors.initials: J
authors.lastname: Calleja-Gonzalez
authors.affiliation: Faculty of Sport Sciences, University of Extremadura, Extremadura, Spain.
authors.forename: Guillermo
authors.initials: G
authors.lastname: Olcina
authors.affiliation: Faculty of Kinesiology, University of Split, Split, Croatia.
authors.forename: Damir
authors.initials: D
authors.lastname: Sekulic
authors.affiliation: Institute of Exercise Physiology and Wellness, University of Central Florida, FL, USA.
authors.forename: Jay R
authors.initials: JR
authors.lastname: Hoffman
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D017079:Exercise Tolerance / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects*; D058573:Performance-Enhancing Substances / Q000627:therapeutic use*; D015990:Placebo Effect; D013449:Sulfonamides / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D058573:Performance-Enhancing Substances; D013449:Sulfonamides; D000077300:Bosentan
keywords: Hepatic enzymes; Maximal oxygen uptake; Pulmonary arterial hypertension